1[1]Pedersen TR. Scandinavian Simvastatin Survival Study Group.Randomized trial of cholesterol-lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study(4S)[J]. Lancet,1994,344(8934):1383.
2[2]Shepherd J, Cobbe SM, Ford I, et al. West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia[J]. N Engl J Med, 1995,333(20):1301.
3[3]Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravasation on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators[J]. N Engl J Med,1996,335(14):1001.
4[4]LIPID Sutdy Group. Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: a randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris[J]. Am J Cardiol,1995,76(7):474.
5[5]Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/Tex CAPS[J]. JAMA,1998,279(20):1615.
6[6]Balduini W, Angelis VD, Mazzoni E, et al. Simvatsatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic/ischemic brain injury[J]. Stroke,2001,32(9):2185.
7[7]Endres M, Laufs U, Huang Z, et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase (cerebral blood flow/cerebral ischemia)[J]. Med Sci,1998,95(15):8880.
8[8]Vaughan CJ, Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke[J]. Stroke,1999,30(9):1969.
9[9]Pantoni L, Sheikh FG, Namboodiri AMS, et al. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages[J]. J Clin Invest,1997,100(11):2671.
10[10]Human JA, Ubbink JB, Jerling JJ, et al. The effect of simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia[J]. Clin Chim Acta,1997,263(1):67.
